- Home
- NMTC vs DYAI Comparison
NMTC vs DYAI Comparison
Compare NMTC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- DYAI
- Stock Information
- Founded
- NMTC 2009
- DYAI 1979
- Country
- NMTC United States
- DYAI United States
- Employees
- NMTC N/A
- DYAI N/A
- Industry
- NMTC Medical/Dental Instruments
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMTC Health Care
- DYAI Health Care
- Exchange
- NMTC Nasdaq
- DYAI Nasdaq
- Market Cap
- NMTC 30.9M
- DYAI 35.5M
- IPO Year
- NMTC N/A
- DYAI 2004
- Fundamental
- Price
- NMTC $0.66
- DYAI $1.04
- Analyst Decision
- NMTC Strong Buy
- DYAI Strong Buy
- Analyst Count
- NMTC 1
- DYAI 1
- Target Price
- NMTC $1.45
- DYAI $6.00
- AVG Volume (30 Days)
- NMTC 390.9K
- DYAI 38.3K
- Earning Date
- NMTC 05-13-2025
- DYAI 05-14-2025
- Dividend Yield
- NMTC N/A
- DYAI N/A
- EPS Growth
- NMTC N/A
- DYAI N/A
- EPS
- NMTC N/A
- DYAI N/A
- Revenue
- NMTC $5,758,777.00
- DYAI $3,495,389.00
- Revenue This Year
- NMTC $292.88
- DYAI $117.40
- Revenue Next Year
- NMTC N/A
- DYAI N/A
- P/E Ratio
- NMTC N/A
- DYAI N/A
- Revenue Growth
- NMTC 54.53
- DYAI 20.58
- 52 Week Low
- NMTC $0.40
- DYAI $0.93
- 52 Week High
- NMTC $1.39
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- NMTC 51.39
- DYAI 28.85
- Support Level
- NMTC $0.61
- DYAI $1.05
- Resistance Level
- NMTC $0.71
- DYAI $1.13
- Average True Range (ATR)
- NMTC 0.05
- DYAI 0.07
- MACD
- NMTC 0.02
- DYAI -0.01
- Stochastic Oscillator
- NMTC 44.03
- DYAI 14.29
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.